| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 647,100 | 691,769 | 680,952 | 563,188 | | Cost of Revenue | 46,500 | (120,576) | 192,520 |
-
| | | Gross Profit | 600,600 | 812,345 | 488,432 | 563,188 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 146,700 | 321,720 | 3,030 | 165,344 | | Non Recurring | 3,200 | 2,774 | 49 | 2,016 | | Others | 64,300 | 69,996 | 63,134 | 52,368 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 386,400 | 417,855 | 422,219 | 343,460 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 4,200 | (216,430) | (6,135) | 13,504 | | Earnings Before Interest And Taxes | 389,400 | 197,796 | 396,027 | 353,023 | | Interest Expense | 38,900 | 86,633 | 27 | 19,459 | | Income Before Tax | 350,500 | 111,163 | 396,000 | 333,564 | | Income Tax Expense | 151,400 | 49,098 | 227,309 | 132,382 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 199,100 | 62,065 | 168,691 | 201,182 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 199,100 | 62,065 | 168,691 | 201,182 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $199,100 | $62,065 | $168,691 | $201,182 |
|
0.45% Nasdaq 
0.20%
Income Statement
